Bioorganic & medicinal chemistry letters Journal

Overview

publication venue for

Erratum to "Development of a novel PI3Kα/CDK7 potent hybrid inhibitor for Cancer treatment" [Bioorg. Med. Chem. Lett. 140 (2026) 130738]. 141:130748. 2026